摘要
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the authors. The authors reported that the in vivo study was performed without the approval from an ethics committee. This is despite previously reporting that the in vivo experiments involved animals were approved by the Animal Care and Use Ethics Committee at their hospital. All authors have agreed to retract the article and apologise to the readership of the journal for any inconvenience caused. “Further concern was raised about several figures of the article”: “A pair of flow-cytometry plots share most of their points in common, and appear to have been derived from the same data set”. The Editors of Pathology Research and Practice consider these concerns as well justified.
| 源语言 | 英语 |
|---|---|
| 文章编号 | 154034 |
| 期刊 | Pathology Research and Practice |
| 卷 | 238 |
| DOI |
|
| 出版状态 | 已出版 - 10月 2022 |
| 已对外发布 | 是 |
学术指纹
探究 'Retraction notice to “Long noncoding RNA LBX2-AS1 drives the progression of hepatocellular carcinoma by sponging microRNA-384 and thereby positively regulating IRS1 expression” [Pathol. - Res. Pract. 216(4) (2020) 152903] (Pathology - Research and Practice (2020) 216(4), (S0344033819328250), (10.1016/j.prp.2020.152903))' 的科研主题。它们共同构成独一无二的指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver